Valuation: AddLife AB

Market Cap 19.69B 2.06B 1.79B 1.67B 1.53B 2.9B 197B 2.94B 7.73B 98.13B 7.75B 7.58B 329B P/E 2026 *
36.8x
P/E 2027 * 29x
Enterprise Value 23.28B 2.44B 2.12B 1.98B 1.81B 3.42B 233B 3.48B 9.14B 116B 9.17B 8.97B 389B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.95x
Free-Float
90.8%
Yield 2026 *
1.04%
Yield 2027 * 1.27%
Manager TitleAgeSince
Chief Executive Officer 54 31/12/2021
Director of Finance/CFO 56 31/12/2021
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 59 04/03/2015
Director/Board Member 57 31/12/2014
Director/Board Member 62 31/12/2014
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.06B
+0.09%+2.56%-16.96%-4.37% 183B
-0.37%+2.62%-4.42%-2.61% 109B
-0.29%+0.47%+7.97%+64.64% 60.57B
+3.50%+0.47%+41.00%+46.44% 51.8B
+0.10%+5.92%-6.10%-40.54% 45.64B
+0.41%+1.37% - - 33.22B
+11.95%+16.65%+5.26%-31.60% 31.49B
+0.40%+3.89%+42.51%-8.26% 24B
-1.22%+6.69%+0.67%+1.96% 22.26B
Average +1.46%+4.86%+8.74%+3.21% 62.35B
Weighted average by Cap. +0.92%+3.49%-0.11%+4.24%

Financials

2026 *2027 *
Net sales 10.9B 1.14B 994M 925M 849M 1.6B 109B 1.63B 4.28B 54.33B 4.29B 4.2B 182B 11.62B 1.22B 1.06B 986M 905M 1.71B 116B 1.74B 4.56B 57.89B 4.57B 4.47B 194B
Net income 535M 56.05M 48.72M 45.35M 41.64M 78.63M 5.35B 79.85M 210M 2.66B 210M 206M 8.93B 679M 71.2M 61.89M 57.61M 52.89M 99.88M 6.8B 101M 267M 3.38B 267M 262M 11.35B
Net Debt 3.59B 376M 327M 304M 279M 528M 35.92B 536M 1.41B 17.88B 1.41B 1.38B 59.96B 2.91B 305M 266M 247M 227M 429M 29.16B 435M 1.14B 14.52B 1.15B 1.12B 48.68B
Logo AddLife AB
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-